Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive treatment option for patients with severe aortic stenosis (narrowing of the aortic valve) [Link to aortic-valve-stenosis.html]. Emory experts have been offering TAVR since 2007, and have performed this treatment successfully on over 1,500 patients, more than any other provider in the Southeast.

During TAVR, Interventional Cardiologists and Cardiothoracic Surgeons work together to replace the aortic valve with catheters through small incisions either in the groin or chest. This technique is performed without opening the chest as in traditional open heart surgery. This minimally invasive approach allows patients to recover more quickly than open chest procedures, reduces the risk of surgical complications, and allows patients to go home sooner than the traditional surgery.

Initially used to treat patients deemed too high-risk for open heart surgery, TAVR has recently been shown to be highly effective in treating medium-risk patients. Emory is a nationally recognized academic center of excellence and offers a vast array of novel technologies and treatment options through FDA approved transcatheter therapies as well as clinical trials. Emory is now offering TAVR to patients of low surgical risk within the PARTNER III clinical trial. 

Download more information about TAVR.

To make an appointment, call 404-778-7777.